Yield Growth Clears Final Hurdle to Market Six New Products in Oregon-- CFN Media

Seattle, Washington--(Newsfile Corp. - June 20, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) and its most recent approvals from the Oregon Liquor Control Commission (OLCC).

The cannabis industry is projected to reach $66.3 billion by 2025, according to Grand View Research, representing a blistering 23.9% compound annual growth rate. While medical and adult-use cannabis capture the headlines, cannabinoid-infused topicals, tinctures and capsules could become some of the fastest growing subsets of the market. Investors may want to take a closer look at this potentially-lucrative corner of the market.

The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3), a health and wellness focused developer of cannabis products, recently secured final packaging approvals from the Oregon Liquor Control Commission (OLCC) for six new THC- and CBD-infused topicals and tinctures to be marketed under the Wright & Well brand.

Let's take a look at the rise of cannabis topicals and tinctures and why the OLCC's approval of six new products could be a transformative event for Yield Growth and its shareholders.

Click here to receive an investor deck and corporate updates

The Rise of Topicals & Tinctures

There are a growing number of cannabis consumption methods and each has its own set of benefits and drawbacks. For instance, cannabis topicals are reshaping the accessibility, safety, and efficacy of cannabinoid consumption and opening the market to consumers that wouldn't otherwise realize the benefits of cannabis. Tinctures similarly provide an easier and more convenient way to consume cannabinoids without smoking, edibles or beverages.

Topicals have become popular for localized pain relief, muscle soreness, tension and inflammation, but emerging science shows potential benefits for psoriasis, dermatitis, itching, headaches, and cramps. They're a go-to solution for many consumers that want to experience less pain following an intense workout or attempt to reduce their use of prescription pharmaceuticals to treat arthritis pain.

Tinctures are alcohol-based extracts that were the primary form of cannabis medicine in the United States until cannabis prohibition. The combination of easy self-titration and a long shelf life makes tinctures one of the most convenient ways to consume cannabis. Consumers don't have to worry about product going bad - as is the case with many edibles and beverages - or having to smoke cannabis to realize the benefits.

Click here to receive an investor deck and corporate updates

Six New Products Approved in Oregon

Yield Growth recently secured final packaging approval from the Oregon Liquor Control Commission, or OLCC, for six new THC- and CBD-infused topicals and tinctures to be marketed under the Wright & Well brand. With the approval in place, the company will begin distributing the products through Nova Paths - an Oregon-based cannabis licensed distributor with relationships with over 400 licensed cannabis retail stores.

"The OLCC packaging approval is one of the most rigorous processes to complete before products can be legally manufactured and sold in Oregon," said Yield Growth CEO Penny Green in a recent press release announcing the approvals. "Now that we have successfully completed the process, we have cleared the final hurdle, and we expect manufacturing to be complete in early July, and sales to begin at the end of July."

The company's six products include:

• Be Chill Tincture (THC: Purple Hindu Kush, CBD: hemp source)
• Be Better CBD Tincture (CBD: hemp source)
• Be Better CBD Extra Strength Tincture (CBD: hemp source)
• Be Relieved Pain Gel (THC: Purple Hindu Kush, CBD: hemp source)
• Be Free Pain Balm (THC: Purple Hindu Kush, CBD: hemp source)
• Be Loved Massage Oil (THC: Purple Hindu Kush, CBD: hemp source)

Click here to receive an investor deck and corporate updates

Looking Ahead

The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) is well positioned to capitalize on rising demand for THC- and CBD-infused topicals and tinctures in Oregon's burgeoning market. With sales expected in July, investors may want to take a closer look at the company as it moves further out of its development stage and into its commercialization stage in the massive cannabis wellness subsector.

For more information, read the company profile or download their investor presentation.

Click here to read the full article:

https://www.cannabisfn.com/yield-growth-clears-final-hurdle-to-market-six-new-products-in-oregon/

About CFN Media

For Visitors and Viewers

CFN Media's Cannabis Financial Network (CannabisFN.com) is the destination for savvy investors and business people profiting from the worldwide cannabis industry. Viewers will see breaking news, exclusive content and original programming involving the people, companies and investments shaping the industry.

For Cannabis Businesses & Companies

CFN Media is a leading agency and financial media network dedicated to the cannabis industry. We help private, pre-public and public cannabis companies in the US and Canada attract capital, investors and media attention.

Our powerful digital media and distribution platform conveys a company's message and value proposition directly to accredited and retail investors and national media active in the North American cannabis markets.

Since 2013, CFN Media has enabled the world's preeminent cannabis companies to thrive in the capital and public markets.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

Contact

CFN Media
Frank Lane
206-369-7050
flane@cannabisfn.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/45761